According to Burning Rock Biotech's latest financial reports and stock price the company's current Operating Margin is -82.78%. At the end of 2023 the company had an Operating Margin of -121.19%.
Year | Operating Margin | Change |
---|---|---|
2023 | -121.19% | -29.58% |
2022 | -172.08% | 9.82% |
2021 | -156.70% | 65.42% |
2020 | -94.73% | 113.74% |
2019 | -44.32% | -47.85% |
2018 | -84.98% | -28.04% |
2017 | -118.09% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() | -1,139.65% | 1,276.72% | ๐บ๐ธ USA |
![]() | -12.21% | -85.25% | ๐บ๐ธ USA |
![]() | 7.37% | -108.90% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.